Literature DB >> 20338780

Massively parallel sequencing, a new method for detecting adventitious agents.

David Onions1, John Kolman.   

Abstract

There has been an upsurge of interest in developing new veterinary and human vaccines and, in turn, this has involved the development of new mammalian and insect cell substrates. Excluding adventitious agents from these cells can be problematic, particularly for cells derived from species with limited virological investigation. Massively parallel sequencing is a powerful new method for the identification of viruses and other adventitious agents, without prior knowledge of the nature of the agent. We have developed methods using random priming to detect viruses in the supernatants from cell substrates or in virus seed stocks. Using these methods we have recently discovered a new parvovirus in bovine serum. When applied to sequencing the transcriptome, massively parallel sequencing can reveal latent or silent infections. Enormous amounts of data are developed in this process usually between 100 and 400 Mbp. Consequently, sophisticated bioinformatic algorithms are required to analyse and verify virus targets. 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20338780     DOI: 10.1016/j.biologicals.2010.01.003

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  9 in total

1.  Rhabdovirus-like endogenous viral elements in the genome of Spodoptera frugiperda insect cells are actively transcribed: Implications for adventitious virus detection.

Authors:  Christoph Geisler; Donald L Jarvis
Journal:  Biologicals       Date:  2016-05-25       Impact factor: 1.856

Review 2.  Electroporation delivery of DNA vaccines: prospects for success.

Authors:  Niranjan Y Sardesai; David B Weiner
Journal:  Curr Opin Immunol       Date:  2011-04-27       Impact factor: 7.486

Review 3.  Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products.

Authors:  Carol Marcus-Sekura; James C Richardson; Rebecca K Harston; Nandini Sane; Rebecca L Sheets
Journal:  Biologicals       Date:  2011-10-13       Impact factor: 1.856

Review 4.  Next-generation sequencing in veterinary medicine: how can the massive amount of information arising from high-throughput technologies improve diagnosis, control, and management of infectious diseases?

Authors:  Steven Van Borm; Sándor Belák; Graham Freimanis; Alice Fusaro; Fredrik Granberg; Dirk Höper; Donald P King; Isabella Monne; Richard Orton; Toon Rosseel
Journal:  Methods Mol Biol       Date:  2015

5.  The origin of biased sequence depth in sequence-independent nucleic acid amplification and optimization for efficient massive parallel sequencing.

Authors:  Toon Rosseel; Steven Van Borm; Frank Vandenbussche; Bernd Hoffmann; Thierry van den Berg; Martin Beer; Dirk Höper
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

6.  Evaluation of the broad-range PCR-electrospray ionization mass spectrometry (PCR/ESI-MS) system and virus microarrays for virus detection.

Authors:  Lanyn P Taliaferro; Teresa A Galvin; Hailun Ma; Syed Shaheduzzaman; Dhanya K Williams; Dustin R Glasner; Arifa S Khan
Journal:  Viruses       Date:  2014-04-25       Impact factor: 5.048

7.  Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing.

Authors:  Edward T Mee; Mark D Preston; Philip D Minor; Silke Schepelmann
Journal:  Vaccine       Date:  2015-12-19       Impact factor: 3.641

8.  A new approach for detecting adventitious viruses shows Sf-rhabdovirus-negative Sf-RVN cells are suitable for safe biologicals production.

Authors:  Christoph Geisler
Journal:  BMC Biotechnol       Date:  2018-02-07       Impact factor: 2.563

9.  The hUC-MSCs cell line CCRC-1 represents a novel, safe and high-yielding HDCs for the production of human viral vaccines.

Authors:  Ping Chen; Ke-Hua Zhang; Tao Na; Lin Wang; Wei-Dong Yin; Bao-Zhu Yuan; Jun-Zhi Wang
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.